ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Higher Peripheral Thyroid Sensitivity Is Linked to a Lower Risk of Heart Failure After Acute Myocardial Infarction

Lang, Xueyan; Zhao, Bing; Fang, Shaohong; Li, Lulu; Li, Zhaoying; Wu, Nilian; Zhang, Yuheng; Xing, Lei*; Li, Yilan*; Zhang, Yao哈尔滨医科大学; y
Journal of Clinical Endocrinology and Metabolism2023-10-18DOI: 10.1210/clinem/dgad240
6阅读
引用收藏
分享

摘要

Context It is still not clear how the free triiodothyronine (FT3) to free thyroxine (FT4) ratio affects the prognosis of acute myocardial infarction (AMI), especially the risk of heart failure (HF) subsequent to AMI. Objective The purpose of this study was to see how peripheral sensitivity to thyroid hormones, as measured by the FT3/FT4 ratio, affected HF and mortality after AMI. Methods Our study was a retrospective cohort study. The primary endpoint was HF after AMI during and after hospitalization. The secondary endpoints were all-cause death and cardiovascular death after hospitalization. Results The main sample included 3648 inpatients with AMI with a median age of 61.0 years; 68.9% were male. In the fully adjusted model, compared with patients in the lowest Q1 of the FT3/FT4 ratio, the risk of in-hospital HF in the highest Q4 patients was reduced by 44% (OR 0.56, 95% CI 0.44-0.72, P trend < .001), the risk of out-of-hospital HF was reduced by 37% (HR 0.63, 95% CI 0.48-0.84, P trend < .001), and the risks of all-cause and cardiovascular death were also significantly reduced. The analysis of different subgroups is consistent with the overall results. Furthermore, the sensitivity analysis of the euthyroid sample of 2484 patients was consistent with the main sample. Mediation analysis showed that altered levels of amino-terminal pro-B-type natriuretic peptide were mediators between the FT3/FT4 ratio and all endpoints in our study. Conclusion The thyroid hormone peripheral sensitivity of the FT3/FT4 ratio is an independent predictor of HF and mortality after AMI.

学科与关键词

关键词
thyroid hormonesperipheral sensitivityFT3FT4 ratioAMIheart failure
相关
加载中…
  • FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk: NHANES 2007-2012
    Lang, Xueyan; Li, Yilan; Zhang, Dandan; Zhang, Yuheng; Wu, Nilian; Zhang, YaoFrontiers in Endocrinology, 2022, 13: 964822.被引 9
  • Free Triiodothyronine Connected With Metabolic Changes in Patients With Coronary Artery Disease by Interacting With Other Functional Indicators
    Tian, Xiao-xue; Zheng, Shu-fen; Liu, Ju-e; Wu, Yuan-yuan; Lin, Lu; Chen, Hong-mei; Li, Li-wen; Qin, Min; Wang, Zi-xian; Zhu, Qian; Lai, Wei-hua*; Zhong, Shilong*Frontiers in Molecular Biosciences, 2021, 8: 681955.
  • Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults
    Wan, Heng; Yu, Genfeng; Xu, Sirong; Chen, Xingying; Jiang, Yuqi; Duan, Hualin; Lin, Xu; Ma, Qintao; Wang, Dongmei; Liang, Yongqian; Liu, Lan*; Shen, Jie*Journal of Clinical Endocrinology and Metabolism, 2023, 108(9): E687-E697.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Clinical Endocrinology and Metabolism
发表日期
2023-10-18
卷期
第 108 卷, 第 11 期
页码
2950-2960
DOI
10.1210/clinem/dgad240
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Lang, Xueyan (第一作者)

    harbin med univ · 2

  • Z

    Zhao, Bing

    harbin med univ · 2

查看全部 10 位作者收起作者
  • F

    Fang, Shaohong

    harbin med univ · 2

  • L

    Li, Lulu

    2 · harbin med univ

  • L

    Li, Zhaoying

    harbin med univ · 2

  • W

    Wu, Nilian

    2 · harbin med univ

  • Z

    Zhang, Yuheng

    2 · harbin med univ

  • X

    Xing, Lei (通讯)

    2 · harbin med univ

  • L

    Li, Yilan (通讯)

    harbin med univ · 2

  • Z

    Zhang, Yao

    harbin med univ · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417